Sol-Gel Technologies Ltd (SLGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The companys pipeline products include vered, twin and sirs-t drug candidates. Its twin drug candidate is a non-antibiotic topical cream developed for the treatment of acne vulgaris or acne. Sol-Gels vered drug candidate is a topical encapsulated benzoyl peroxide cream developed for the treatment of papulopustular rosacea. The companys sirs-t drug candidate is topical encapsulated tretinoin cream developed for the potential treatment of acne. It also develops silica-based microencapsulation technology platform. Sol-Gel is headquartered in Ness Ziona, Israel.

Sol-Gel Technologies Ltd (SLGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Sol-Gel Technologies Enters into Agreement with CMO 11
Sol-Gel Technologies Amended Development Agreement with Perrigo 12
Licensing Agreements 13
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 13
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 14
Equity Offering 15
Sol-Gel Tech Raises USD86.3 Million in IPO of Shares 15
Acquisition 17
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 17
Sol-Gel Technologies Ltd - Key Competitors 18
Sol-Gel Technologies Ltd - Key Employees 19
Sol-Gel Technologies Ltd - Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
May 15, 2018: Sol-Gel Technologies Announces First Quarter 2018 Financial Results 21
Mar 26, 2018: Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results 22
Clinical Trials 24
Feb 15, 2018: Sol-Gel presents Phase 2 Data on VERED at the 2018 American Academy of Dermatology Annual Meeting 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Sol-Gel Technologies Enters into Agreement with CMO 11
Sol-Gel Technologies Amended Development Agreement with Perrigo 12
Douglas Pharma Enters into Licensing Agreement with Sol-Gel Technologies 13
Sol-Gel Technologies Enters Into Licensing Agreement With US-Based Pharma Company For Dermatologic Drug 14
Sol-Gel Tech Raises USD86.3 Million in IPO of Shares 15
Mori Arkin Plans to Acquire Sol-Gel for USD10 Million 17
Sol-Gel Technologies Ltd, Key Competitors 18
Sol-Gel Technologies Ltd, Key Employees 19

List Of Figures


Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sol-Gel Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sol-Gel Technologies Ltd, Medical Devices Deals, 2012 to YTD 2018 9

Sol-Gel Technologies Ltd (SLGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The companys pipeline

USD 250 View Report

Sol-Gel Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The companys pipeline

USD 250 View Report

Covalon Technologies Ltd (COV) - Product Pipeline Analysis, 2018 Update

Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound

USD 750 View Report

Rectifier Technologies Ltd (RFT) - Financial and Strategic SWOT Analysis Review

Rectifier Technologies Ltd (Rectifier Tech) is an industrial equipment provider that designs, manufactures and markets rectifier systems. The company offers rectifier systems which include controllers, cabinets and ancillaries. Its products

USD 300 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available